Age-based versus Risk-based Mammography Screening in Women 40-49 Years Old: A Cross-sectional Study
- PMID: 31184557
- PMCID: PMC6694720
- DOI: 10.1148/radiol.2019181651
Age-based versus Risk-based Mammography Screening in Women 40-49 Years Old: A Cross-sectional Study
Abstract
Background Risk-based screening in women 40-49 years old has not been evaluated in routine screening mammography practice. Purpose To use a cross-sectional study design to compare the trade-offs of risk-based and age-based screening for women 45 years of age or older to determine short-term outcomes. Materials and Methods A retrospective cross-sectional study was performed by using a database of 20 539 prospectively interpreted consecutive digital screening mammograms in 10 280 average-risk women aged 40-49 years who were screened at an academic medical center between January 1, 2006, and December 31, 2013. Two hypothetical screening scenarios were compared: an age-based (≥45 years) scenario versus a risk-based (a 5-year risk of breast cancer greater than that of an average 50-year-old) scenario. Risk factors for risk-based screening included family history, race, age, prior breast biopsy, and breast density. Outcomes included breast cancers detected at mammography, false-positive mammograms, and benign biopsy findings. Short-term outcomes were compared by using the χ2 test. Results The screening population included 71 148 screening mammograms in 24 928 women with a mean age of 55.5 years ± 8.9 (standard deviation) (age range, 40-74 years). In women 40-49 years old, usual care included 50 screening-detected cancers, 1787 false-positive mammograms, and 384 benign biopsy results. The age-based (≥45 years) screening strategy revealed more cancers than did the risk-based strategy (34 [68%] vs 13 [26%] of 50; P < .001), while prompting more false-positive mammograms (899 [50.3%] vs 216 [12.1%] of 1787; P < .001) and benign biopsy results (175 [45.6%] vs 49 [12.8%] of 384; P < .001). The risk-based strategy demonstrated low levels of eligibility (few screenings) in the 40-44-year age group. Differences in outcomes in the 45-49-year age group explained the overall hypothetical screening strategy differences. Conclusion Risk-based screening for women 40-49 years old includes few women in the 40-44-year age range. Significant trade-offs in the 45-49-year age group explain the overall difference between hypothetical screening scenarios, both of which reduce the benefits as well as the harms of mammography for women 40-49 years old. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Joe and Hayward in this issue.
Figures


Comment in
-
More Lives Risked with Risk-based versus Age-based Breast Cancer Screening.Radiology. 2019 Aug;292(2):329-330. doi: 10.1148/radiol.2019191040. Epub 2019 Jun 11. Radiology. 2019. PMID: 31184982 No abstract available.
Similar articles
-
Interval and Consecutive Round Breast Cancer after Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Standard 2D Digital Mammography in BreastScreen Norway.Radiology. 2020 Feb;294(2):256-264. doi: 10.1148/radiol.2019191337. Epub 2019 Dec 10. Radiology. 2020. PMID: 31821118
-
Factors Impacting False Positive Recall in Screening Mammography.Acad Radiol. 2019 Nov;26(11):1505-1512. doi: 10.1016/j.acra.2019.01.020. Epub 2019 Feb 14. Acad Radiol. 2019. PMID: 30772138
-
Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.JAMA Oncol. 2016 Jun 1;2(6):737-43. doi: 10.1001/jamaoncol.2015.5536. JAMA Oncol. 2016. PMID: 26893205
-
Screening mammography in women less than age 50 years.Curr Opin Obstet Gynecol. 2012 Feb;24(1):38-43. doi: 10.1097/GCO.0b013e32834da49a. Curr Opin Obstet Gynecol. 2012. PMID: 22037165 Review.
-
Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.CMAJ. 2001 Feb 20;164(4):469-76. CMAJ. 2001. PMID: 11233866 Free PMC article. Review.
Cited by
-
Framing the Clinical Encounter: Shared Decision-Making, Mammography Screening, and Decision Satisfaction.J Health Commun. 2020 Sep 1;25(9):681-691. doi: 10.1080/10810730.2020.1838003. Epub 2020 Oct 28. J Health Commun. 2020. PMID: 33111640 Free PMC article.
-
Breast cancer risk stratification for mammographic screening: A nation-wide screening cohort of 24,431 women in Singapore.Cancer Med. 2021 Nov;10(22):8182-8191. doi: 10.1002/cam4.4297. Epub 2021 Oct 28. Cancer Med. 2021. PMID: 34708579 Free PMC article.
-
Preliminary Evaluation of a Breast Cancer Screening Shared Decision-Making Aid Utilized Within the Primary Care Clinical Encounter.J Patient Exp. 2021 Jul 31;8:23743735211034039. doi: 10.1177/23743735211034039. eCollection 2021. J Patient Exp. 2021. PMID: 34377770 Free PMC article.
-
Impact of personalised risk predictions on breast cancer risk perceptions: insights from the BREATHE study.J Transl Med. 2025 May 8;23(1):517. doi: 10.1186/s12967-025-06515-1. J Transl Med. 2025. PMID: 40340901 Free PMC article.
-
The current status of risk-stratified breast screening.Br J Cancer. 2022 Mar;126(4):533-550. doi: 10.1038/s41416-021-01550-3. Epub 2021 Oct 26. Br J Cancer. 2022. PMID: 34703006 Free PMC article. Review.
References
-
- What are the top causes of death by age and gender? http://visual.ons.gov.uk/what-are-the-top-causes-of-death-by-age-and-gen.... Accessed October 26, 2018 .
-
- Leading Causes of Death in Females, 2014 (current listing) . https://www.cdc.gov/women/lcod/2014/all-females/index.htm. Accessed October 26, 2018 .
-
- NHS Public Health Function Agreement 2015-16: Breast Screening Programme . London, England: : Department of Health; , 2014. . https://assets.publishing.service.gov.uk/government/uploads/system/uploa.... Accessed October 26, 2018 .
-
- Siu AL; U.S. Preventive Services Task Force . Screening for breast cancer: U.S. preventive services task force recommendation statement . Ann Intern Med 2016. ; 164 ( 4 ): 279 – 296 . - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical